ConductScience.org, home

Paper35613596

Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.

Pfaff-Kilgore JM and 12 others. Cell Rep, 2022. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Papers, record 35613596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35613596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.
PubMed
Journal
Cell Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2025-07-28
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pfaff-Kilgore JMJennifer M
2Davidson EEdgar
3Kadash-Edmondson KKathryn
4Hernandez MMayda
5Rosenberg EErin
6Chambers RRoss
7Castelli MMatteo
8Clementi NNicola
9Mancini NNicasio
10Bailey JRJustin R
11Crowe JE JrJames E
12Law MMansun
13Doranz BJBenjamin J

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HepacivirusMajor topic
Hepatitis CMajor topic
Alanine
Antibodies, Monoclonal
Humans
Viral Envelope Proteins
Virus Internalization

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U19 AI159822NIAID NIH HHSUnited StatesU19AI159822PubMed and NIHNIH RePORTER
R01 AI127469NIAID NIH HHSUnited StatesR01AI127469PubMed and NIHNIH RePORTER
R24 AI158193NIAID NIH HHSUnited StatesR24AI158193PubMed and NIHNIH RePORTER
R21 AI151353NIAID NIH HHSUnited StatesR21AI151353PubMed and NIHNIH RePORTER
U19 AI123861NIAID NIH HHSUnited StatesU19AI123861PubMed and NIHNIH RePORTER
R01 AI123365NIAID NIH HHSUnited StatesR01AI123365PubMed and NIHNIH RePORTER
HHSN272201400058CNIAID NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

References111

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111145889The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation.Virology2001https://conductscience.org/library/papers/11145889PubMed
222278231Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.J Virol2012https://conductscience.org/library/papers/22278231PubMed
329769329Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29769329PubMed
416103160Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.J Virol2005https://conductscience.org/library/papers/16103160PubMed
517374757Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1.J Gen Virol2007https://conductscience.org/library/papers/17374757PubMed
628100619Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a trans-Complementation System Reveals a Dual Role of a Putative Fusion Peptide of E1 in both HCV Entry and Morphogenesis.J Virol2017https://conductscience.org/library/papers/28100619PubMed
722623528Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22623528PubMed
824158478Atomic-level functional model of dengue virus Envelope protein infectivity.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24158478PubMed
930068644Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.J Virol2018https://conductscience.org/library/papers/30068644PubMed
1019891955Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein.Biochim Biophys Acta2010https://conductscience.org/library/papers/19891955PubMed
1115159545The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15159545PubMed
1222492964Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22492964PubMed
1311559832Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.J Virol2001https://conductscience.org/library/papers/11559832PubMed
1427121372Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain.Sci Rep2016https://conductscience.org/library/papers/27121372PubMed
1530443787Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy.Arch Immunol Ther Exp (Warsz)2019https://conductscience.org/library/papers/30443787PubMed
1636264808Structure of the hepatitis C virus E1E2 glycoprotein complex.Science2022https://conductscience.org/library/papers/36264808PubMed
1725172800HCV E2 core structures and mAbs: something is still missing.Drug Discov Today2014https://conductscience.org/library/papers/25172800PubMed
1827543332Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27543332PubMed
1929253863Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.PLoS Pathog2017https://conductscience.org/library/papers/29253863PubMed
2010400776Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.J Virol1999https://conductscience.org/library/papers/10400776PubMed

See all 111 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42945244Hepatitis C viral variants bear signatures of de novo CD8+ T cell and antibody pressure after spontaneous postpartum viral suppression.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42945244PubMed
42642377Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers.Nat Commun2026https://conductscience.org/library/papers/42642377PubMed
41939904Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance.Front Immunol2026https://conductscience.org/library/papers/41939904PubMed
41542449mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope.bioRxiv2026https://conductscience.org/library/papers/41542449PubMed
41481431Antibody responses to a highly conserved peptide in HCV E2 protein correlate with chronicity or spontaneous clearance of HCV infection.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41481431PubMed
41076628Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design.Cell Rep2025https://conductscience.org/library/papers/41076628PubMed
40766312Non-cognate ligands of hepatitis C virus envelope broadly neutralizing antibodies induce virus-neutralizing sera in mice.Front Immunol2025https://conductscience.org/library/papers/40766312PubMed
40153382Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies.PLoS Pathog2025https://conductscience.org/library/papers/40153382PubMed
39232163The hepatitis C virus envelope protein complex is a dimer of heterodimers.Nature2024https://conductscience.org/library/papers/39232163PubMed
38833465The red alga Porphyridium as a host for molecular farming: Efficient production of immunologically active hepatitis C virus glycoprotein.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38833465PubMed
38793684Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.Viruses2024https://conductscience.org/library/papers/38793684PubMed
38171391A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns.Virus Res2024https://conductscience.org/library/papers/38171391PubMed
38107333HCV E1 influences the fitness landscape of E2 and may enhance escape from E2-specific antibodies.Virus Evol2023https://conductscience.org/library/papers/38107333PubMed
38084956Hepatitis C virus modified sE2F442NYT as an antigen in candidate vaccine facilitates human immune cell activation.J Virol2024https://conductscience.org/library/papers/38084956PubMed
37432947Structures of the Hepaci-, Pegi-, and Pestiviruses envelope proteins suggest a novel membrane fusion mechanism.PLoS Biol2023https://conductscience.org/library/papers/37432947PubMed
37419906Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins.Nat Commun2023https://conductscience.org/library/papers/37419906PubMed
37407593Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies.Nat Commun2023https://conductscience.org/library/papers/37407593PubMed
37243237Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies.Viruses2023https://conductscience.org/library/papers/37243237PubMed
36920705Pseudotyped Virus for Flaviviridae.Adv Exp Med Biol2023https://conductscience.org/library/papers/36920705PubMed
36264808Structure of the hepatitis C virus E1E2 glycoprotein complex.Science2022https://conductscience.org/library/papers/36264808PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35613596

GET https://conductscience.org/api/papers/v1/35613596/references?page=2